{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T11:48:39Z","timestamp":1793015319306,"version":"4.5.0"},"reference-count":49,"publisher":"Japanese Society of Toxicologic Pathology","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Toxicol Pathol"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1293\/tox.2021-0018","type":"journal-article","created":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T22:09:52Z","timestamp":1645826992000},"page":"193-203","source":"Crossref","is-referenced-by-count":31,"title":["LPS-TLR4\/MD-2\u2013TNF-\u03b1 signaling mediates alcohol-induced liver fibrosis in rats"],"prefix":"10.1293","volume":"35","author":[{"given":"Wen-Ling","family":"Mou","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Heilongjiang Province Hospital, No. 82, Zhongshan Road, Xiangfang District, Harbin 150000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Ru","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Heilongjiang Province Hospital, No. 82, Zhongshan Road, Xiangfang District, Harbin 150000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Ting","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Heilongjiang Province Hospital, No. 82, Zhongshan Road, Xiangfang District, Harbin 150000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Hua","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Heilongjiang Province Hospital, No. 82, Zhongshan Road, Xiangfang District, Harbin 150000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Ye","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Heilongjiang Province Hospital, No. 82, Zhongshan Road, Xiangfang District, Harbin 150000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Jie","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Heilongjiang Province Hospital, No. 82, Zhongshan Road, Xiangfang District, Harbin 150000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Heilongjiang Province Hospital, No. 82, Zhongshan Road, Xiangfang District, Harbin 150000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Heilongjiang Province Hospital, No. 82, Zhongshan Road, Xiangfang District, Harbin 150000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"121","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Liu X, Wu Y, Yang Y, Li W, Huang C, Meng X, and Li J. Role of NLRC5 in progression and reversal of hepatic fibrosis. Toxicol Appl Pharmacol. 294: 43\u201353. 2016.","DOI":"10.1016\/j.taap.2016.01.012"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Zheng H, Wang X, Zhang Y, Chen L, Hua L, and Xu W. Pien-Tze-Huang ameliorates hepatic fibrosis via suppressing NF-\u03baB pathway and promoting HSC apoptosis. J Ethnopharmacol. 244: 111856. 2019.","DOI":"10.1016\/j.jep.2019.111856"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. George J, Tsuchishima M, and Tsutsumi M. Molecular mechanisms in the pathogenesis of N-nitrosodimethylamine induced hepatic fibrosis. Cell Death Dis. 10: 18. 2019.","DOI":"10.1038\/s41419-018-1272-8"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Shay JES, and Hamilton JP. Hepatic fibrosis: avenues of investigation and clinical implications. Clin Liver Dis (Hoboken). 11: 111\u2013114. 2018.","DOI":"10.1002\/cld.702"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Zhou WC, Zhang QB, and Qiao L. Pathogenesis of liver cirrhosis. World J Gastroenterol. 20: 7312\u20137324. 2014.","DOI":"10.3748\/wjg.v20.i23.7312"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. George J, Tsuchishima M, and Tsutsumi M. Metabolism of N-nitrosodimethylamine, methylation of macromolecules, and development of hepatic fibrosis in rodent models. J Mol Med (Berl). 98: 1203\u20131213. 2020.","DOI":"10.1007\/s00109-020-01950-7"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Shan L, Liu Z, Ci L, Shuai C, Lv X, and Li J. Research progress on the anti-hepatic fibrosis action and mechanism of natural products. Int Immunopharmacol. 75: 105765. 2019.","DOI":"10.1016\/j.intimp.2019.105765"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Wu H, Chen G, Wang J, Deng M, Yuan F, and Gong J. TIM-4 interference in Kupffer cells against CCL4-induced liver fibrosis by mediating Akt1\/Mitophagy signalling pathway. Cell Prolif. 53: e12731. 2020.","DOI":"10.1111\/cpr.12731"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Duffield JS, Forbes SJ, Constandinou CM, Clay S, Partolina M, Vuthoori S, Wu S, Lang R, and Iredale JP. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest. 115: 56\u201365. 2005.","DOI":"10.1172\/JCI200522675"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Lodder J, Dena\u00ebs T, Chobert MN, Wan J, El-Benna J, Pawlotsky JM, Lotersztajn S, and Teixeira-Clerc F. Macrophage autophagy protects against liver fibrosis in mice. Autophagy. 11: 1280\u20131292. 2015.","DOI":"10.1080\/15548627.2015.1058473"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Klingberg F, Hinz B, and White ES. The myofibroblast matrix: implications for tissue repair and fibrosis. J Pathol. 229: 298\u2013309. 2013.","DOI":"10.1002\/path.4104"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Qu C, Zheng D, Li S, Liu Y, Lidofsky A, Holmes JA, Chen J, He L, Wei L, Liao Y, Yuan H, Jin Q, Lin Z, Hu Q, Jiang Y, Tu M, Chen X, Li W, Lin W, Fuchs BC, Chung RT, and Hong J. Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis. Hepatology. 68: 1125\u20131139. 2018.","DOI":"10.1002\/hep.29881"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Tsuchida T, and Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 14: 397\u2013411. 2017.","DOI":"10.1038\/nrgastro.2017.38"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. George J, Tsutsumi M, and Tsuchishima M. MMP-13 deletion decreases profibrogenic molecules and attenuates N-nitrosodimethylamine-induced liver injury and fibrosis in mice. J Cell Mol Med. 21: 3821\u20133835. 2017.","DOI":"10.1111\/jcmm.13304"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ying HZ, Chen Q, Zhang WY, Zhang HH, Ma Y, Zhang SZ, Fang J, and Yu CH. PDGF signaling pathway in hepatic fibrosis pathogenesis and therapeutics (Review). Mol Med Rep. 16: 7879\u20137889. 2017.","DOI":"10.3892\/mmr.2017.7641"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Huang Y, Deng X, and Liang J. Modulation of hepatic stellate cells and reversibility of hepatic fibrosis. Exp Cell Res. 352: 420\u2013426. 2017.","DOI":"10.1016\/j.yexcr.2017.02.038"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Zhang CY, Yuan WG, He P, Lei JH, and Wang CX. Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets. World J Gastroenterol. 22: 10512\u201310522. 2016.","DOI":"10.3748\/wjg.v22.i48.10512"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Tomita K, Tamiya G, Ando S, Ohsumi K, Chiyo T, Mizutani A, Kitamura N, Toda K, Kaneko T, Horie Y, Han JY, Kato S, Shimoda M, Oike Y, Tomizawa M, Makino S, Ohkura T, Saito H, Kumagai N, Nagata H, Ishii H, and Hibi T. Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice. Gut. 55: 415\u2013424. 2006.","DOI":"10.1136\/gut.2005.071118"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Osawa Y, Hoshi M, Yasuda I, Saibara T, Moriwaki H, and Kozawa O. Tumor necrosis factor-\u03b1 promotes cholestasis-induced liver fibrosis in the mouse through tissue inhibitor of metalloproteinase-1 production in hepatic stellate cells. PLoS One. 8: e65251. 2013.","DOI":"10.1371\/journal.pone.0065251"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Yoshiji H, Kuriyama S, Miyamoto Y, Thorgeirsson UP, Gomez DE, Kawata M, Yoshii J, Ikenaka Y, Noguchi R, Tsujinoue H, Nakatani T, Thorgeirsson SS, and Fukui H. Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model. Hepatology. 32: 1248\u20131254. 2000.","DOI":"10.1053\/jhep.2000.20521"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Ma C, Liu A, Wang Y, Geng X, Hao L, Song Q, Sun B, Wang H, and Zhao G. The hepatocyte phase of Gd-EOB-DTPA-enhanced MRI in the evaluation of hepatic fibrosis and early liver cirrhosis in a rat model: an experimental study. Life Sci. 108: 104\u2013108. 2014.","DOI":"10.1016\/j.lfs.2014.05.016"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Shen X, Guo H, Xu J, and Wang J. Inhibition of lncRNA HULC improves hepatic fibrosis and hepatocyte apoptosis by inhibiting the MAPK signaling pathway in rats with nonalcoholic fatty liver disease. J Cell Physiol. 234: 18169\u201318179. 2019.","DOI":"10.1002\/jcp.28450"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Iqbal U, Dennis BB, Li AA, Cholankeril G, Kim D, Khan MA, and Ahmed A. Use of anti-platelet agents in the prevention of hepatic fibrosis in patients at risk for chronic liver disease: a systematic review and meta-analysis. Hepatol Int. 13: 84\u201390. 2019.","DOI":"10.1007\/s12072-018-9918-2"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Tan Z, Liu Q, Jiang R, Lv L, Shoto SS, Maillet I, Quesniaux V, Tang J, Zhang W, Sun B, and Ryffel B. Interleukin-33 drives hepatic fibrosis through activation of hepatic stellate cells. Cell Mol Immunol. 15: 388\u2013398. 2018.","DOI":"10.1038\/cmi.2016.63"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Su GL. Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation. Am J Physiol Gastrointest Liver Physiol. 283: G256\u2013G265. 2002.","DOI":"10.1152\/ajpgi.00550.2001"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Szabo G, and Bala S. Alcoholic liver disease and the gut-liver axis. World J Gastroenterol. 16: 1321\u20131329. 2010.","DOI":"10.3748\/wjg.v16.i11.1321"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Mandrekar P, and Szabo G. Signalling pathways in alcohol-induced liver inflammation. J Hepatol. 50: 1258\u20131266. 2009.","DOI":"10.1016\/j.jhep.2009.03.007"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Hu N, Wang C, Dai X, Zhou M, Gong L, Yu L, Peng C, and Li Y. Phillygenin inhibits LPS-induced activation and inflammation of LX2 cells by TLR4\/MyD88\/NF-\u03baB signaling pathway. J Ethnopharmacol. 248: 112361. 2020.","DOI":"10.1016\/j.jep.2019.112361"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Miller AM, Horiguchi N, Jeong WI, Radaeva S, and Gao B. Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines. Alcohol Clin Exp Res. 35: 787\u2013793. 2011.","DOI":"10.1111\/j.1530-0277.2010.01399.x"},{"key":"30","unstructured":"30. Lu X, Wang B, Xie Y, Liu C, and Fu B. [Dynamic change and expression of matrix metalloproteinase-2, -9 in alcoholic liver disease in rats]. Zhonghua Gan Zang Bing Za Zhi. 9: 268\u2013270. 2001 (in Chinese)."},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Li PZ, Li JZ, Li M, Gong JP, and He K. An efficient method to isolate and culture mouse Kupffer cells. Immunol Lett. 158: 52\u201356. 2014.","DOI":"10.1016\/j.imlet.2013.12.002"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Zhang Q, Qu Y, Li Z, Zhang Q, Xu M, Cai X, Li F, and Lu L. Isolation and culture of single cell types from rat liver. Cells Tissues Organs. 201: 253\u2013267. 2016.","DOI":"10.1159\/000444672"},{"key":"33","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","year":"2001","unstructured":"33. Livak KJ, and Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25: 402\u2013408. 2001.","journal-title":"Methods A Companion to Methods in Enzymology","ISSN":"https:\/\/id.crossref.org\/issn\/1046-2023","issn-type":"print"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Hemmann S, Graf J, Roderfeld M, and Roeb E. Expression of MMPs and TIMPs in liver fibrosis\u2014a systematic review with special emphasis on anti-fibrotic strategies. J Hepatol. 46: 955\u2013975. 2007.","DOI":"10.1016\/j.jhep.2007.02.003"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Yao L, Kan EM, Lu J, Hao A, Dheen ST, Kaur C, and Ling EA. Toll-like receptor 4 mediates microglial activation and production of inflammatory mediators in neonatal rat brain following hypoxia: role of TLR4 in hypoxic microglia. J Neuroinflammation. 10: 23. 2013.","DOI":"10.1186\/1742-2094-10-23"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Peng Y, Gong JP, Liu CA, Li XH, Gan L, and Li SB. Expression of toll-like receptor 4 and MD-2 gene and protein in Kupffer cells after ischemia-reperfusion in rat liver graft. World J Gastroenterol. 10: 2890\u20132893. 2004.","DOI":"10.3748\/wjg.v10.i19.2890"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Miyake K. Endotoxin recognition molecules, Toll-like receptor 4-MD-2. Semin Immunol. 16: 11\u201316. 2004.","DOI":"10.1016\/j.smim.2003.10.007"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Re F, and Strominger JL. Separate functional domains of human MD-2 mediate Toll-like receptor 4-binding and lipopolysaccharide responsiveness. J Immunol. 171: 5272\u20135276. 2003.","DOI":"10.4049\/jimmunol.171.10.5272"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Akashi-Takamura S, Furuta T, Takahashi K, Tanimura N, Kusumoto Y, Kobayashi T, Saitoh S, Adachi Y, Doi T, and Miyake K. Agonistic antibody to TLR4\/MD-2 protects mice from acute lethal hepatitis induced by TNF-alpha. J Immunol. 176: 4244\u20134251. 2006.","DOI":"10.4049\/jimmunol.176.7.4244"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Csak T, Velayudham A, Hritz I, Petrasek J, Levin I, Lippai D, Catalano D, Mandrekar P, Dolganiuc A, Kurt-Jones E, and Szabo G. Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice. Am J Physiol Gastrointest Liver Physiol. 300: G433\u2013G441. 2011.","DOI":"10.1152\/ajpgi.00163.2009"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Yin X, Gong X, Jiang R, Kuang G, Wang B, Zhang L, Xu G, and Wan J. Emodin ameliorated lipopolysaccharide-induced fulminant hepatic failure by blockade of TLR4\/MD2 complex expression in D-galactosamine-sensitized mice. Int Immunopharmacol. 23: 66\u201372. 2014.","DOI":"10.1016\/j.intimp.2014.08.018"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Gustot T, Lemmers A, Moreno C, Nagy N, Quertinmont E, Nicaise C, Franchimont D, Louis H, Devi\u00e8re J, and Le Moine O. Differential liver sensitization to toll-like receptor pathways in mice with alcoholic fatty liver. Hepatology. 43: 989\u20131000. 2006.","DOI":"10.1002\/hep.21138"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Soares JB, Pimentel-Nunes P, Roncon-Albuquerque R, and Leite-Moreira A. The role of lipopolysaccharide\/toll-like receptor 4 signaling in chronic liver diseases. Hepatol Int. 4: 659\u2013672. 2010.","DOI":"10.1007\/s12072-010-9219-x"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Ma B, Hottiger M O. Crosstalk between Wnt\/b-Catenin and\nNF-kB signaling pathway during inflammation. Frontiers\nin Immunology. 7: 378. 2016.","DOI":"10.3389\/fimmu.2016.00378"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Ke B, Shen XD, Kamo N, Ji H, Yue S, Gao F, Busuttil RW, and Kupiec-Weglinski JW. \u03b2-catenin regulates innate and adaptive immunity in mouse liver ischemia-reperfusion injury. Hepatology. 57: 1203\u20131214. 2013.","DOI":"10.1002\/hep.26100"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Singh S, Arcaroli J, Thompson DC, Messersmith W, and Vasiliou V. Acetaldehyde and retinaldehyde-metabolizing enzymes in colon and pancreatic cancers. Adv Exp Med Biol. 815: 281\u2013294. 2015.","DOI":"10.1007\/978-3-319-09614-8_16"},{"key":"47","doi-asserted-by":"publisher","unstructured":"47. Tessoulin B, Descamps G, Moreau P, Ma\u00efga S, Lod\u00e9 L, Godon C, Marionneau-Lambot S, Oullier T, Le Gouill S, Amiot M, and Pellat-Deceunynck C. PRIMA-1Met induces myeloma cell death independent of p53 by impairing the GSH\/ROS balance. Blood. 124: 1626\u20131636. 2014.","DOI":"10.1182\/blood-2014-01-548800"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Lushehak VI. Free radicals, reactive oxygen species, oxidative stress and its classification. Chemico Bio Int. 224: 16417. 2016.","DOI":"10.1016\/j.cbi.2014.10.016"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Ling L, Nurcombe V, Cool SM. Wnt sigIlaling contmls the fate of mesenchymal stem cells. 433: 1-7. 2009.","DOI":"10.1016\/j.gene.2008.12.008"}],"container-title":["Journal of Toxicologic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tox\/35\/2\/35_2021-0018\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T05:42:47Z","timestamp":1650087767000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tox\/35\/2\/35_2021-0018\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1293\/tox.2021-0018","relation":{},"ISSN":["0914-9198","1881-915X"],"issn-type":[{"value":"0914-9198","type":"print"},{"value":"1881-915X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"2021-0018"}}